MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS

被引:511
作者
CHEN, RT
MARKOWITZ, LE
ALBRECHT, P
STEWART, JA
MOFENSON, LM
PREBLUD, SR
ORENSTEIN, WA
机构
[1] CTR DIS CONTROL,CTR INFECT DIS,DIV VIRAL DIS,ATLANTA,GA 30333
[2] US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20014
[3] MASSACHUSETTS DEPT PUBL HLTH,DIV COMMUNICABLE DIS CONTROL,BOSTON,MA
关键词
D O I
10.1093/infdis/162.5.1036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A school blood drive before a measles outbreak permitted correlation of preexposure measles antibody titers with clinical protection using the plaque reduction neutralization (PRN) test and an EIA. Of 9 donors with detectable preexposure PRN titer ≤120, 8 met the clinical criteria for measles (7 seroconfirmed) compared with none of 71 with preexposure PRN titers >120 (P <.0001). Seven of 11 donors with preexposure PRN titers of 216–874 had a ≥-fold rise in antibody titer (mean, 43-fold) compared with none of 7 with a preexposure PRN titer ≥1052 (P <.02). Of 37 noncases with preexposure PRN titer <1052, 26 (70%) reported one or more symptoms compared with 11 (31%) of 35 donors with preexposure PRN titers ≥1052 (P <.002). By EIA, no case had detectable preexposure antibody; the preexposure geOlpetric mean titer of asymptomatic donors (220) was not significantly higher than that of symptomatic donors who did not meet the clinical criteria for measles (153) (P =.10). The study suggests that PRN titers ≤120 were not protective against measles disease and illness without rash due to measles may occur in persons with PRN titers above this level. © 1990, by The University of Chicago.
引用
收藏
页码:1036 / 1042
页数:7
相关论文
共 41 条
[1]   PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS - MECHANISM OF MEASLES-VACCINE FAILURE [J].
ALBRECHT, P ;
ENNIS, FA ;
SALTZMAN, EJ ;
KRUGMAN, S .
JOURNAL OF PEDIATRICS, 1977, 91 (05) :715-718
[2]   ROLE OF VIRUS-STRAIN IN CONVENTIONAL AND ENHANCED MEASLES PLAQUE NEUTRALIZATION TEST [J].
ALBRECHT, P ;
HERRMANN, K ;
BURNS, GR .
JOURNAL OF VIROLOGICAL METHODS, 1981, 3 (05) :251-260
[3]  
BELLANTI JA, 1985, IMMUNOLOGY, P566
[4]  
BRANDLIN.AD, 1973, JAMA-J AM MED ASSOC, V224, P616
[5]   ANTIBODY-RESPONSE FOLLOWING MEASLES-MUMPS-RUBELLA VACCINE UNDER CONDITIONS OF CUSTOMARY USE [J].
BRUNELL, PA ;
WEIGLE, K ;
MURPHY, MD ;
SHEHAB, Z ;
COBB, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (11) :1409-1412
[6]   CLINICAL AND SEROLOGIC STUDY OF 103 CHILDREN WITH MEASLES VACCINE FAILURE [J].
CHERRY, JD ;
FEIGIN, RD ;
SHACKELFORD, PG ;
HINTHORN, DR ;
SCHMIDT, RR .
JOURNAL OF PEDIATRICS, 1973, 82 (05) :802-808
[7]   URBAN MEASLES IN VACCINE ERA - CLINICAL, EPIDEMIOLOGIC, AND SEROLOGIC STUDY [J].
CHERRY, JD ;
SHIRLEY, RH ;
SHACKELFORD, PG ;
LOBES, LA ;
LINS, RD ;
HINTHORN, DR ;
CHOI, SC ;
FEIGIN, RD .
JOURNAL OF PEDIATRICS, 1972, 81 (02) :217-+
[8]  
CHERRY JD, 1972, PEDIATRICS, V50, P712
[9]   ENZYME-IMMUNOASSAY VERSUS PLAQUE NEUTRALIZATION AND OTHER METHODS FOR DETERMINATION OF IMMUNE STATUS TO MEASLES AND VARICELLA-ZOSTER VIRUSES AND VERSUS COMPLEMENT-FIXATION FOR SERODIAGNOSIS OF INFECTIONS WITH THOSE VIRUSES [J].
CREMER, NE ;
COSSEN, CK ;
SHELL, G ;
DIGGS, J ;
GALLO, D ;
SCHMIDT, NJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (06) :869-874
[10]   MEASLES REVACCINATION - PERSISTENCE AND DEGREE OF ANTIBODY TITER BY TYPE OF IMMUNE-RESPONSE [J].
DESEDATOUS, J ;
CHERRY, JD ;
SPENCER, MJ ;
WELLIVER, RC ;
BOYER, KM ;
DUDLEY, JP ;
ZAHRADNIK, JM ;
KRAUSE, PJ ;
WALBERGH, EW .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1978, 132 (03) :287-290